FGL1 and neoplasm: Given that hepatocytes have been reported to secrete FGL1 in the liver microenvironment15, we knocked down FGL1 in hepatocytes via injecting recombinant adeno-associated virus (AAV) targeting hepatocyte-specific FGL1 and found that metastatic tumor progression was also significantly suppressed (Fig. 1E–H, S1G).